Colorectal cancer surveillance post-surgery

Hospital Medicine

Volumn 62, Issue 8, 2001, Pages 490-491

  Huang, Andy ^a,b   Hindle, Kirsten S ^a   Tsavellas, George ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

BLOOD; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; FLOW CYTOMETRY; HUMAN; IMAGE PROCESSING; LIVER TUMOR; METABOLISM; METASTASIS; POLYMERASE CHAIN REACTION; REVIEW; SECOND CANCER; SENSITIVITY AND SPECIFICITY; STANDARD;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; NEOPLASMS, SECOND PRIMARY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035430329     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2001.62.8.1626     Document Type: Article

References (14)

1. Ahlquist DA (2000) Molecular stool screening for colorectal cancer. Br MeJ J 321: 254-5
2. Allen-Mersh TG, Earlam S, Fordy C, Abrams K. Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver métastases. Lancet 344: 1255-60
3. Andreyev HJ, Norman AR, Cunningham D, Oates JR. Clarkc PA (1998) Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J Natl Cancer hist 90: 675-84
4. Bohm B. Schwenk W, Hucke HR Stock W (1993) Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dix Colon Rectum 36: 280 6
5. Castells A, Boix L, Bessa X. Gargallo L, Pique JM (1998) Detection of colonie cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymcrase chain reaction. Br J Cancer 78: 1368-72
6. Expert Advisory Group (1996) Guidelines for the Management of Colorcctal Cancer. The Royal College of Surgeons of England, London
7. Hardingham JE, Hewett PJ, Sage RE et al (2000) Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease, hit 7Cuntc';-89:8-13
8. Lindemann F, Schlimok G, Dirschedl R Witte J. Riethmuller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-9
9. Mocrtel CCJ, Fleming TR. Macdonald JS, Haller DG. Laurie JA. Tangen C (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-7
10. Nigro JM. Baker S.I. Preisingcr AC et al (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-8
11. O'Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F (1997) Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 40: 512-5
12. Scheele J. Altendorf-Hofmann A (1999) Resection of colorectal liver métastases. Langenbecks Arch Snrg 384: 313-27
13. Taniguchi T, Makino M. Suzuki K, Kaibara N (2000) Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinocmbryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89: 970-6
14. Tornqvist A, Ekelund G. Leandoer L (1982) The value of intensive follow-up after curative resection for colorectal carcinoma, BrJSurg69: 725-8